Role and Mechanism of Action of Complement in Regulating T Cell Immunity

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2010 Jul 7

PMID 20603023

Citations 35

Authors

Jason R Dunkelberger

Wen-Chao Song

Affiliations

Soon will be listed here.

Abstract

Complement is a part of the innate immune system that contributes to first-line host defense. It is also implicated in a number of human inflammatory conditions and has attracted interest as a potential therapeutic target. Understanding the basic biology of complement and its mechanism(s) of action is imperative for developing complement-based treatments for infectious and autoimmune diseases. One of the exciting new developments in this regard is the revelation that complement plays an important role in T cell immunity. In this review, we highlight recent published studies implicating complement in models of CD4+ and CD8+ T cell immune responses, and discuss its potential mechanism(s) action in these processes. We also comment on issues that may impact data interpretation and draw attention to their consideration in future studies.

Citing Articles

Complement and T cell activation in transplantation.

Alibrandi S, Clemens A, Chun N Transplant Rev (Orlando). 2024; 39(1):100898.

PMID: 39615218 PMC: 11710966. DOI: 10.1016/j.trre.2024.100898.

Traditional Chinese Medicine Erhuang Suppository for Treatment of Persistent High-risk Human Papillomavirus Infection and Its Impact on Transcriptome of Uterine Cervix.

Wang Z, Wang H, Xiong W, Du J, Liu R Curr Med Sci. 2024; 44(4):841-853.

PMID: 39039373 DOI: 10.1007/s11596-024-2898-7.

Tissue-resident C1q + macrophages exert anti-aging potential through the Sirt1 pathway.

Liu L, Zhu L, Liang Q, Yu L, Hu L, Yu Y Inflamm Res. 2024; 73(7):1069-1080.

PMID: 38724770 DOI: 10.1007/s00011-024-01883-8.

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice.

Diamos A, Pardhe M, Bergeman M, Kamzina A, DiPalma M, Aman S Front Immunol. 2023; 14:1085911.

PMID: 37205110 PMC: 10186352. DOI: 10.3389/fimmu.2023.1085911.

Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation.

Yunis J, Short K, Yu D Trends Microbiol. 2023; 31(6):644-656.

PMID: 36635162 PMC: 9829516. DOI: 10.1016/j.tim.2022.12.008.

References

Wills-Karp M . Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc. 2007; 4(3):247-51. PMC: 2647626. DOI: 10.1513/pats.200704-046AW. View

Bao L, Haas M, Pippin J, Wang Y, Miwa T, Chang A . Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest. 2009; 119(5):1264-74. PMC: 2673859. DOI: 10.1172/JCI36000. View

Chen A, Gaddipati S, Hong Y, Volkman D, Peerschke E, Ghebrehiwet B . Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol. 1994; 153(4):1430-40. View

Suresh M, Molina H, Salvato M, Mastellos D, Lambris J, Sandor M . Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol. 2003; 170(2):788-94. DOI: 10.4049/jimmunol.170.2.788. View

Kohl J, Wills-Karp M . Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol Immunol. 2006; 44(1-3):44-56. DOI: 10.1016/j.molimm.2006.06.016. View

Lalli P, Strainic M, Yang M, Lin F, Medof M, Heeger P . Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood. 2008; 112(5):1759-66. PMC: 2518884. DOI: 10.1182/blood-2008-04-151068. View

Nataf S, Carroll S, Wetsel R, Szalai A, Barnum S . Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol. 2000; 165(10):5867-73. DOI: 10.4049/jimmunol.165.10.5867. View

Vriesendorp F, FLYNN R, Pappolla M, Koski C . Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis. Int J Neurosci. 1998; 92(3-4):287-98. DOI: 10.3109/00207459708986406. View

Smith S, Ludwig M, Wohler J, Bullard D, Szalai A, Barnum S . Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice. Neurosci Lett. 2008; 442(2):158-60. PMC: 2556246. DOI: 10.1016/j.neulet.2008.07.005. View

10.

Barchet W, Price J, Cella M, Colonna M, MacMillan S, Cobb J . Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation. Blood. 2005; 107(4):1497-504. PMC: 1895395. DOI: 10.1182/blood-2005-07-2951. View

11.

Carroll M . The complement system in B cell regulation. Mol Immunol. 2004; 41(2-3):141-6. DOI: 10.1016/j.molimm.2004.03.017. View

12.

Zwirner J, Gotze O, Begemann G, Kapp A, Kirchhoff K, Werfel T . Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology. 1999; 97(1):166-72. PMC: 2326815. DOI: 10.1046/j.1365-2567.1999.00764.x. View

13.

Morgan B, Griffiths M, Khanom H, Taylor S, Neal J . Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin Exp Immunol. 2004; 138(3):430-8. PMC: 1809229. DOI: 10.1111/j.1365-2249.2004.02646.x. View

14.

Baelder R, Fuchs B, Bautsch W, Zwirner J, Kohl J, Hoymann H . Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J Immunol. 2005; 174(2):783-9. DOI: 10.4049/jimmunol.174.2.783. View

15.

Hikono H, Kohlmeier J, Ely K, Scott I, Roberts A, Blackman M . T-cell memory and recall responses to respiratory virus infections. Immunol Rev. 2006; 211:119-32. DOI: 10.1111/j.0105-2896.2006.00385.x. View

16.

Holers V, Kulik L . Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol Immunol. 2006; 44(1-3):64-72. DOI: 10.1016/j.molimm.2006.07.003. View

17.

van Montfoort N, de Jong J, Schuurhuis D, van der Voort E, Camps M, Huizinga T . A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. J Immunol. 2007; 178(12):7581-6. DOI: 10.4049/jimmunol.178.12.7581. View

18.

Ramos T, Wohler J, Barnum S . Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis. Neurosci Lett. 2009; 467(3):234-6. PMC: 2784262. DOI: 10.1016/j.neulet.2009.10.045. View

19.

Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris J . Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood. 2007; 110(1):228-36. PMC: 1896115. DOI: 10.1182/blood-2006-12-063636. View

20.

Mehlhop E, Whitby K, Oliphant T, Marri A, Engle M, Diamond M . Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol. 2005; 79(12):7466-77. PMC: 1143684. DOI: 10.1128/JVI.79.12.7466-7477.2005. View